HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
RE 1492
improves storage of whole blood & red blood cells
Also Known As:
N,N',N''-tris(4-phenylbutyl)benzene-1,3,5-trimethanamine; RE-1492
Networked:
4
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Amines: 4871
Polyamines: 3918
RE 1492: 4
Related Diseases
1.
Hemolysis
04/01/1995 - "
A concentration of 50 mumol/L RE 1492 drops hemolysis by 50%.
"
08/01/1994 - "
RE 1492 caused a decrease of osmotic hemolysis by 80% at concentrations of 8 mumol/L.
"
08/01/1990 - "
With 100 mumols/L RE 1492 only one fifth of the haemolysis of untreated WB occurs.
"
04/01/1995 - "
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability.
"
2.
Thrombosis (Thrombus)
04/01/1995 - "
The combined effects of the oligoamine RE 1492 with the NO-donor RE 2047 or ASA, ticlopidine, pentoxifylline and BM 14515 were determined in vitro (Born-test) and in vivo (rat thrombosis model).
"
Related Drugs and Biologics
1.
Ticlopidine (Ticlid)
2.
Potassium
3.
Pentoxifylline (Trental)
4.
Anticoagulants
5.
Adenosine Triphosphate (ATP)
6.
3-methylsydnone-5-nitrosimine